plasma cell neoplasm (Cancer)
Information
- Disease name
- plasma cell neoplasm
- Disease ID
- DOID:6536
- Description
- "A mature B-cell neoplasm that is composed of plasma cells." [url:https\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C4665]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01484015 | Completed | Phase 1 | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia | February 2011 | October 2012 |
| NCT00028600 | Completed | Phase 2 | Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma | November 2001 | February 2010 |
| NCT00053196 | Completed | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer | December 2002 | August 2010 |
| NCT00064038 | Completed | Phase 3 | S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma | November 2004 | May 2012 |
| NCT00005792 | Completed | Phase 1 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | June 2, 1998 | November 1, 2018 |
| NCT00118339 | Completed | N/A | Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma | July 2003 | May 2006 |
| NCT04080531 | Completed | Phase 4 | Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders | October 18, 2019 | December 15, 2022 |
| NCT00400686 | Completed | N/A | Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma | September 2003 | August 2013 |
| NCT00536601 | Completed | N/A | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | June 29, 2006 | July 9, 2018 |
| NCT00547365 | Completed | Phase 1/Phase 2 | Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction | October 2007 | July 2011 |
| NCT00602693 | Completed | Phase 1 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | July 23, 2007 | April 16, 2015 |
| NCT00729118 | Completed | Phase 1 | Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | September 26, 2008 | May 4, 2020 |
| NCT02556931 | Completed | Phase 2 | Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies | December 2015 | April 2021 |
| NCT00874211 | Completed | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | December 2008 | June 2019 | |
| NCT00890747 | Completed | Phase 1 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | August 2009 | |
| NCT00891137 | Completed | Phase 1 | Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | April 2009 | June 2014 |
| NCT01132833 | Completed | Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy | December 2008 | January 2016 | |
| NCT01219010 | Completed | Phase 1 | A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma | October 2010 | March 2014 |
| NCT05336383 | Recruiting | Phase 2 | Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma | May 31, 2022 | December 7, 2024 |
| NCT04354246 | Recruiting | Phase 1 | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies | March 31, 2020 | March 30, 2025 |
| NCT00790842 | Terminated | Phase 1/Phase 2 | Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction | January 21, 2009 | March 8, 2018 |
| NCT00303719 | Terminated | Phase 2 | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | March 26, 2002 | May 8, 2019 |
| NCT00075608 | Terminated | Phase 2 | 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis | August 2001 | October 2011 |
| NCT03999697 | Unknown status | Phase 1 | A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies | December 1, 2018 | December 1, 2020 |
| NCT01558778 | Withdrawn | N/A | Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant | May 2012 |
- Disase is a (Disease Ontology)
- DOID:706
- Cross Reference ID (Disease Ontology)
- EFO:0000200
- Cross Reference ID (Disease Ontology)
- MESH:D010265
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:71390001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1136084
- Exact Synonym (Disease Ontology)
- Plasma cell dyscrasia
- Exact Synonym (Disease Ontology)
- Plasma cell tumour
- Exact Synonym (Disease Ontology)
- Plasmacytic tumor